logo

Biomarin Pharmaceutical Inc. (BMRN)



Trade BMRN now with
  Date
  Headline
12/22/2017 12:09:49 PM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $110 Price Target
12/22/2017 8:31:02 AM BioMarin Gets Anticipated Notification Of PDUFA Extension For Pegvaliase BLA To May 28, 2018
12/20/2017 11:51:06 AM Wedbush Reiterates Biomarin Pharmaceutical Inc. (BMRN) At Outperform With $110 Price Target
12/14/2017 9:16:46 AM Wedbush Raises Biomarin Pharmaceutical Inc. (BMRN) To Outperform From Neutral With $110 Up From $108 Price Target
12/14/2017 9:15:35 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) 2018 Estimate To -0.21 From -0.88
12/14/2017 9:15:21 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 4Q18 Estimate To 0.02 From -0.15
12/14/2017 9:15:01 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) 3Q18 Estimate To -0.04 From -0.21
12/14/2017 9:14:40 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) 2Q18 Estimate To -0.02 From -0.19
12/14/2017 9:14:24 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 1Q18 Estimate To -0.17 From -0.32
12/14/2017 9:13:56 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 2017 Estimate To -0.50 From -0.64
12/14/2017 9:13:36 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 4Q17 Estimate To -0.12 From -0.26
12/14/2017 9:12:52 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) 2018 Rev. Estimate To 1449.8 M From 1442.4 M
12/14/2017 9:12:33 AM Wedbush Is Increasing Biomarin Pharmaceutical Inc. (BMRN) 4Q18 Rev. Estimate To 379.9 M From 375.4 M
12/14/2017 9:09:39 AM Wedbush Is Raising Biomarin Pharmaceutical Inc. (BMRN) 2Q18 Rev. Estimate To 369.3 M From 366.5 M
12/14/2017 9:09:20 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) 1Q18 Rev. Estimate To 335.3 M From 337.7 M
12/14/2017 9:08:56 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) 2017 Rev. Estimate To 1285.8 M From 1290.8 M
12/14/2017 9:08:32 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) 4Q17 Rev. Estimate To 330.6 M From 335.5 M
12/11/2017 10:01:31 AM BioMarin Announces Updates On Valoctocogene Roxaparvovec (formerly BMN 270) At ASH